To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Patient Power The difference between non-small cell lung cancer and small cell lung cancer is an important distinction when diagnosing lung cancer because it can change the course of a patient’s treatment plan. Hirva Mamdani, M.D. , medical oncologist and leader of the Thoracic Oncology Multidisciplinary Team at Karmanos, explained the importance of knowing the difference between the two kinds. Read the article here .
Hour Detroit’s 2025 Top Docs List is out; over 80 physicians from the Barbara Ann Karmanos Cancer Institute are listed. This year’s magazine also features a Karmanos physician on the cover. Each year, Hour Detroit Magazine puts out an online peer-to-peer review survey conducted by Professional Research Services (PRS) to determine the top physicians in southeastern Michigan. Participating physicians in Livingston, Macomb, Oakland, Washtenaw, and Wayne Counties nominate the best doctors ...
WebMD There are many tools that oncologists use to confirm a lung cancer diagnosis, and many different treatments are available. Hirva Mamdani, M.D. , medical oncologist, leader of the Thoracic Oncology Multidisciplinary Team (MDT) and the director of the Lung Cancer Screening Program at Karmanos, explained what a blood test can tell oncologists about lung cancer, and how immunotherapy has changed survival outcomes for patients compared to the most advanced lung cancer treatments...